Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primates.
Authors: Pouliopoulos AN, Kwon N, Jensen G, Meaney A, Niimi Y, Burgess MT, Ji R, McLuckie AJ, Munoz FA, Kamimura HAS, Teich AF, Ferrera VP, Konofagou EE
An emerging approach with potential in improving the treatment of neurodegenerative diseases and brain tumors is the use of focused ultrasound (FUS) to bypass the blood-brain barrier (BBB) in a non-invasive and localized manner. A large body of pre-clinical work has paved the way for the gradual clinical implementation of FUS-induced BBB opening. Even though the safety profile of FUS treatments in rodents has been extensively studied, the histological and behavioral effects of clinically relevant BBB opening in large animals are relatively understudied. Here, we examine the histological and behavioral safety profile following localized BBB opening in non-human primates (NHPs), using a neuronavigation-guided clinical system prototype. We show that FUS treatment triggers a short-lived immune response within the targeted region without exacerbating the touch accuracy or reaction time in visual-motor cognitive tasks. Our experiments were designed using a multiple-case-study approach, in order to maximize the acquired data and support translation of the FUS system into human studies. Four NHPs underwent a single session of FUS-mediated BBB opening in the prefrontal cortex. Two NHPs were treated bilaterally at different pressures, sacrificed on day 2 and 18 post-FUS, respectively, and their brains were histologically processed. In separate experiments, two NHPs that were earlier trained in a behavioral task were exposed to FUS unilaterally, and their performance was tracked for at least 3 weeks after BBB opening. An increased microglia density around blood vessels was detected on day 2, but was resolved by day 18. We also detected signs of enhanced immature neuron presence within areas that underwent BBB opening, compared to regions with an intact BBB, confirming previous rodent studies. Logistic regression analysis showed that the NHP cognitive performance did not deteriorate following BBB opening. These preliminary results demonstrate that neuronavigation-guided FUS with a single-element transducer is a non-invasive method capable of reversibly opening the BBB, without substantial histological or behavioral impact in an animal model closely resembling humans. Future work should confirm the observations of this multiple-case-study work across animals, species and tasks.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To evaluate the histological and behavioral safety profile following a single procedure of focused ultrasound-mediated blood–brain barrier opening using a clinical system prototype in a non-human primate model.
Animal model / Human subject
Rhesus macaques, 7.5 ± 0.5 years old
Disease model
Healthy
MRI or image guidance method
Neuronavigation-guided
Targeted brain region(s)
Prefrontal Cortex (Pfc)
Outcomes and Safety
Summary of Outcomes
Neuronavigation-guided FUS successfully and reversibly opened the BBB in the prefrontal cortex of macaques at pressures of 200 and 400 kPa. The procedure caused no lasting behavioral deficits and only a short-lived immune response that resolved by day 18.
Duration of biological effect
18 days
Safety-related matter
The procedure induced a transient immune response and minor focal edema that fully resolved by day 18, with no cognitive deterioration or acute hemorrhage observed.
Brain Region
Ultrasound Parameters
Ultrasound instrument
Single-element transducer (neuronavigation-guided clinical system prototype)
FUS Frequency
0.25 MHz
FUS Pressure
200 kPa and 400 kPa
FUS Mode
pulsed
Pulse duration
10 ms
Duration of a single FUS session
2 min
Focal Characteristics
Focal depth: 49 mm
Treatment frequency
Single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search